The optimal methods for surveillance are MRI, physical examination, and monitoring of tumor markers: carcinoembryonic antigen (CEA), CA 19-9, and diabetes—hemoglobin A1c. This evidence concerns the gene CEACAM5 and diabetes mellitus.